NCT00853086View on ClinicalTrials.gov

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Interventions
DRUG

activated recombinant human factor VII

Safety data collection in connection with the use of the drug NovoSeven® in daily clinical practice

Trial Locations (1)

RH11 9RT

Novo Nordisk Investigational Site, Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY